Adagrasib in Combination With Palbociclib in Patients With Advanced Solid Tumors (KRYSTAL-16)
Clinical trial NCT05178888 · COMPLETED
Trial details
- NCT number
- NCT05178888
- Sponsor
- Mirati Therapeutics Inc.
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-01-20
- Primary completion
- 2023-06-15
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.